Pacific Biosciences of California Struggles in the Second Quarter With Lower Sales

Pacific Biosciences of California Struggles in the Second Quarter With Lower Sales

Pacific Biosciences of California (NASDAQ: PACB) didn't fare so well the last time it provided a quarterly update. After the genetic-sequencing company reported its first-quarter results in late April, its bigger-than-expected net loss rattled investors. 

The company announced its second-quarter results after the market closed on Wednesday, and the news wasn't any better than earlier this year. Here are the highlights. 

Image source: Getty Images.

Continue reading

Source: Fool.com